Skip to Main Content

Paper Details

Virologic and Immunologic Characterization of COVID-19 Recrudescence after Nirmatrelvir/Ritonavir Treatment.
Res Sq
20
2022
COVID-19, Nirmatrelvir, Ritonavir, SARS-, SARS-CoV, SARS-CoV-2, nirmatrelvir, person, ritonavir
Author NameAffiliation
Aaron F Carlinuniversity of california san diego.
Davey M Smithuniversity of california san diego.
  • 1 - 2

Datasets

Release 1.2